Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|May 29, 2019
Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)Sayyed Mohammad Ismail Mahboubi Rabbani, Afshin ZarghiMolecular Diversity|July 7, 2025
Novel dual inhibitor targeting FAAH and sEH: Design, synthesis, and in-vitro evaluation of oxadiazole analoguesMaryam Salehi, Anna Sedaghat, Maryam Bayanati, et al.Iranian Journal of Pharmaceutical Research : IJPR|January 20, 2025
Dual COX-2/TNF-α Inhibitors as Promising Anti-inflammatory and Cancer Chemopreventive Agents: A ReviewMobina Tajdari, Amirreza Peyrovinasab, Maryam Bayanati, et al.Iranian Journal of Pharmaceutical Research : IJPR|March 11, 2025
Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review of Structure-Activity Relationship StudiesMaryam Bayanati, Mohammad Ismail Mahboubi Rabbani, Shirin Sirous Kabiri, et al.Iranian Journal of Pharmaceutical Research : IJPR|July 22, 2026
A New Survey about Dual-Acting PARP/COX-2 Inhibitors as Cancer Chemopreventive AgentsMohammad Ismail Mahboubi Rabbani, Ali Aliabadi, Leila Bayat, et al.Pageof 1